Lindsay Machan

Interventional Radiologist at Vancouver Hospital. Cofounder Ikomed Technologies and Angiotech, Inc, Angiotech Pharmaceuticals

Role: Fellow

Sites: CDL-Rockies, CDL-Vancouver

Streams: Biomedical Engineering, Prime

Dr. Lindsay Machan is an interventional radiologist at the Vancouver Hospital and Associate Professor of Radiology at the University of British Columbia. In 2010, Dr. Machan cofounded Ikomed Technologies,a company which created and licensed an FDA approved method for reducing radiation dose during medical proceduresis currently developing a non-invasive method for treating chronic obstructive lung disease. In 1993 he cofounded Angiotech Pharmaceuticals, which developed and licensed the paclitaxel-coated stent. At present, he sits on commercial and scientific advisory boards for multiple Canadian and US medical companies and is actively involved in clinical practice, research, and teaching at Vancouver Hospital. He is also an active angel investor. He was made an Officer of the Order of Canada in 2024.